Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Challenging homografts as the holy grail for aortic valve endocarditis

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Intrinsic cardiac stem cells are essential for regeneration

Abracadabra I, II…HeartMate 3?

Form ever follows function

Bicuspid aortic valve aortopathy: One size fits all?

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

The variability of the mitral valve anatomy and terminology

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,

Michele Gallo, MD, Gino Gerosa, MD

Military surgeons just want to have fun

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Giant pseudoaneurysm after proximal aortic surgery treated by means of redo axillary artery cannulation and use of an Endoclamp device Francois Dagenais,

The aortic valve–sparing operation

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Torsten Doenst, MD, PhD, Markus Richter, MD

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

Which is the “lord” of the aortic rings?

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Sinus of Valsalva aneurysms: Stabilizing the repair destabilizing the aortic valve? M. Sertaç Çiçek, MD, FACC The Journal of Thoracic and Cardiovascular.

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

A fate worse than death Jennifer S. Lawton, MD

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Commentary: Do the right thing! Ethical versus legal

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

The Mitroflow aortic valve: A past, present, and future illuminated

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

First nights, the adrenal axis, and steroids

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Early extubation after cardiac surgery: The evolution continues

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

First in line for robotic surgery: Would you want to know?

Apples remain apples NO matter what

Preoperative PFTs: The answer is blowing in the wind

Use of the endoclamp device in a patient with a native mitral valve endocarditis and a previous arch replacement with a modified Griepp technique Siamak.

Journal changes and initiatives

Lessons learned from Melody valve retrieved at transplantation

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine, MD, D. Desaulniers, MD, J. Perron, MD, R. Baillot, MD, G. Raymond, MD, J. Métras, MD, D. Doyle, MD, P. Mathieu, MD The Journal of Thoracic and Cardiovascular Surgery Volume 129, Issue 5, Pages 1041-1049 (May 2005) DOI: 10.1016/j.jtcvs.2004.10.041 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Freedom from all death. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 1041-1049DOI: (10.1016/j.jtcvs.2004.10.041) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from cardiac death. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 1041-1049DOI: (10.1016/j.jtcvs.2004.10.041) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Freedom from reoperation. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 1041-1049DOI: (10.1016/j.jtcvs.2004.10.041) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions